| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
328.14(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$163.84 - $216.66 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 173 |
| Guru Rank Value : 8 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
58,832 |
278,893 |
630,038 |
1,170,454 |
| Total Sell Value |
$12,359,504 |
$57,730,353 |
$119,941,840 |
$213,262,231 |
| Total People Sold |
1 |
6 |
6 |
9 |
| Total Sell Transactions |
1 |
10 |
13 |
26 |
| End Date |
2025-03-27 |
2024-12-24 |
2024-06-25 |
2023-06-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Falk Thomas J |
|
– • – |
2025-05-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,000 |
|
1% |
|
| Falk Thomas J |
|
– • – |
2025-05-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,203 |
|
1% |
|
| Davis Jennifer L. |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
2,525 |
|
- |
|
| Falk Thomas J |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
1,203 |
|
- |
|
| Rapp Edward J |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
34,458 |
|
- |
|
| Waddell Frederick H |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
28,958 |
|
- |
|
| Freyman Thomas C |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
126,751 |
|
- |
|
| Austin Roxanne S |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
38,458 |
|
- |
|
| Hart Brett J |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
19,472 |
|
- |
|
| Quaggin Susan E |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
2,525 |
|
- |
|
| Burnside William H.l. |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
26,958 |
|
- |
|
| Tilton Glenn F |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
51,564 |
|
- |
|
| Meyer Melody B |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
16,498 |
|
- |
|
| Alpern Robert J |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
35,646 |
|
- |
|
| Roberts Rebecca B |
|
– • – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
13,728 |
|
- |
|
| Stewart Jeffrey Ryan |
EVP, CHIEF COMMERCIAL OFFICER |
• – – |
2025-03-31 |
4 |
S |
$209.49 |
$12,359,504 |
D/D |
(58,832) |
53,234 |
|
11% |
|
| Stewart Jeffrey Ryan |
EVP, CHIEF COMMERCIAL OFFICER |
• – – |
2025-03-31 |
4 |
OE |
$79.02 |
$2,030,814 |
D/D |
25,700 |
112,066 |
|
- |
|
| Gonzalez Richard A |
|
– • – |
2025-03-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,450 |
386,479 |
|
- |
|
| Reents Scott T |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2025-03-14 |
4 |
S |
$212.34 |
$3,746,527 |
D/D |
(17,644) |
11,577 |
|
12% |
|
| Richmond Timothy J. |
EVP, CHIEF HR OFFICER |
• – – |
2025-03-03 |
4 |
S |
$209.80 |
$4,472,039 |
D/D |
(21,250) |
6,130 |
|
12% |
|
| Gonzalez Richard A |
|
– • – |
2025-03-03 |
4 |
S |
$210.53 |
$1,298,549 |
D/D |
(6,168) |
388,929 |
|
12% |
|
| Siatis Perry C |
EVP, GC AND SECRETARY |
• – – |
2025-03-03 |
4 |
S |
$210.00 |
$3,781,680 |
D/D |
(18,008) |
4,619 |
|
12% |
|
| Siatis Perry C |
EVP, GC AND SECRETARY |
• – – |
2025-03-03 |
4 |
OE |
$144.54 |
$2,879,040 |
D/D |
18,008 |
22,627 |
|
- |
|
| Purdue David Ryan |
SVP, Controller |
• – – |
2025-03-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
527 |
|
-12% |
|
| Purdue David Ryan |
SVP, Controller |
• – – |
2025-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,505 |
|
-12% |
|
648 Records found
|
|
Page 1 of 26 |
|
|
0.16 (0.09%) 
